USA Africa Dialogue Series - Fwd: Instead of looking for PhD positions, design your own

---------- Forwarded message ---------
From: Nature Briefing <briefing@nature.com>
Date: Mon, 3 Feb 2020 at 19:35
Subject: Instead of looking for PhD positions, design your own
To: <toyin.adepoju@gmail.com>

What matters in science | 

View this email in your browser Monday 3 February 2020

Hello Nature readers, Today we learn that live samples of the coronavirus are heading to labs worldwide, and find out what virologists are planning to do with them. Plus, we discover tech tools to help make labs more open and inclusive, and learn how to design our own doctoral projects.

Coronavirus outbreak Coloured transmission electron micrograph of three coronavirus particles. (Dr Linda Stannard/UCT/Science Photo Library) Labs worldwide clamour for live samples On Thursday, the World Health Organization (WHO) recommended that the interim name of the disease causing the current outbreak should be "2019-nCoV acute respiratory disease" (where 'n' stands for novel and 'CoV' for coronavirus). It might not roll off the tongue, but there is a good reason for the choice. Disease names that point to a landmark or region — such as 'Spanish flu' — can cause harm. "We've seen certain disease names provoke a backlash against members of particular religious or ethnic communities, create unjustified barriers to travel, commerce and trade, and trigger needless slaughtering of food animals," said the WHO's Keiji Fukuda in a 2015 statement on naming new diseases. (Forbes | 3 min read) Genome sequences of 2019-nCoV have been available since early January, but these are no substitute for live samples of the virus, which are needed to study it in depth. With samples expected to be disseminated widely within days, meet the virologists drawing up plans to test drugs and vaccines, develop animal models of the infection and investigate how the virus spreads. (Nature | 4 min read) The New York Times offers a quick, infographic-driven overview of what we know about 2019-nCoV compared to other diseases: how contagious it is (moderately), how deadly (we don't know, but probably less than 3% of infections are fatal) and how long it will take to develop a vaccine (probably a year, at least). (The New York Times | 11 min read) The United States, Australia and Singapore are among the countries that are denying entry to foreign nationals who have travelled in China in the previous 14 days. Several other countries have ceased flights to China or closed their borders to the country, against the advice of the WHO. "Travel restrictions can cause more harm than good by hindering info-sharing, medical supply chains and harming economies," says WHO director-general Tedros Adhanom Ghebreyesus. The WHO recommends screening at border crossings instead. (BBC | 6 min read) Stay up to date with the latest news on the outbreak on Nature. (short reads, continuously updated)

Notable quotable "It is precisely developed countries like the United States with strong epidemic prevention capabilities and facilities that have taken the lead in imposing excessive restrictions contrary to WHO recommendations." The US travel ban on visitors to China will "create and spread fear", says Chinese foreign-ministry spokesperson Hua Chunying. (Reuters)

Major HIV vaccine study fails An ambitious HIV vaccine trial in South Africa has been halted early after the treatment was deemed to have no efficacy compared to a placebo. The study examined the 'prime boost' strategy, in which participants received a pair of complementary HIV vaccines. A smaller study in Thailand a decade ago showed lacklustre results, but researchers still held out hope based on results in monkeys. "It's a huge disappointment," says physician-scientist Glenda Gray, who headed the curtailed study. "I was catatonic." Science | 6 min read

Features & opinion

Tech tools for open and inclusive labs Apps and software tools are helping many inclusivity-minded group leaders to transform research from an isolated pursuit into a more open, collective exercise. Messaging platforms to make discussions more transparent, video conferencing for offsite lab members and software to support people with learning differences can all contribute. Plus, there are lower-tech solutions, such as posting your lab's code of conduct on a public-facing website. Nature | 8 min read

Design your own doctoral project Instead of looking for PhD positions, why not design your own, suggests fisheries researcher Jesko Becker. He reveals how he created his dream doctoral project in his perfect location — and outlines hurdles to watch out for. Nature | 6 min read

How to master the art of prioritization Business researcher Carsten Lund Pedersen has come up with a simple tool to help scientists pick, prioritize and pursue the right research project. The project-management triangle measures three key constraints that researchers should consider: ambition, time and energy. "We need to be making clever choices on tricky trade-offs," says Pederson. Nature Index | 5 min read

Quirks of Nature

Quote of the day "I think my goals for Davos have been downgraded from delivering a message of peace and nerd liberation to the world's powerful, or even getting a selfie with Greta, to simply taking in a week in an environment that's so alien to me." Theoretical computer scientist Scott Aaronson gives us the scientist's-eye-view of the World Economic Forum in Davos, Switzerland (Shtetl-Optimized blog)

Artist Simon Weckert put 99 second-hand smartphones in a trolley and slowly rolled them down a Berlin street to convince Google Maps there was a traffic jam. While I take a stroll down my own road, why not help keep this newsletter flowing freely? Please send your feedback to briefing@nature.com. (p.s. Don't forget to enter to win a Lunar New Year Nature mouse. We've extended the deadline by four more days by popular demand.) Flora Graham, senior editor, Nature Briefing

Join our community

You received this newsletter because you subscribed with the email address: toyin.adepoju@gmail.com Forwarded by a friend? Get the Briefing straight to your inbox: subscribe for free. Had enough? Unsubscribe from the Nature Briefing. Fancy a bit of a read? View our privacy policy. Enjoying this newsletter? Please recommend it to a friend or colleague. Use this form to forward it by email. Nature | The Springer Nature Campus, 4 Crinan Street, London, N1 9XW, United Kingdom Nature Research, part of Springer Nature. © 2020 Springer Nature Limited. All rights reserved.

--
Listserv moderated by Toyin Falola, University of Texas at Austin
To post to this group, send an email to USAAfricaDialogue@googlegroups.com
To subscribe to this group, send an email to USAAfricaDialogue+subscribe@googlegroups.com
Current archives at http://groups.google.com/group/USAAfricaDialogue
Early archives at http://www.utexas.edu/conferences/africa/ads/index.html
---
You received this message because you are subscribed to the Google Groups "USA Africa Dialogue Series" group.
To unsubscribe from this group and stop receiving emails from it, send an email to usaafricadialogue+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/usaafricadialogue/CALUsqTT%3DAbrL93mDTHcP9qp9XfWAD%2BUK1qGDPksHoKJAfYdxXA%40mail.gmail.com.